CCO Slideset
VEGF Targeted Therapy in Ovarian Cancer: Basis & Directions
 |
|
Robert A. Burger, MD, discusses the rationale for using VEGF inhibitors in ovarian cancer and reviews current phase II and III trials evaluating these agents in the frontline and recurrent setting.
Format: Microsoft PowerPoint (.ppt) |
File size: 2.96 MB
| Date posted: 2/11/2009
|
*You must be logged into the clinicaloptions.com site to view or save the slides.
Users are encouraged to use these slides in their own presentations, but we ask that content and attribution not be changed. Users are asked to honor this intent. These slides may not be published or posted online without permission from Clinical Care Options.
|
|
|